company

VETTRE APOTEK AS

1392 VETTRE

Return on Equity
10,69 %
Current Ratio
1,18
Debt-to-Equity Ratio
−1,71
Key figures (NOK)2022
Revenue10 834 000
Net Income−94 000
Total Assets1 866 000
Total Equity−879 000
Income (NOK)2022
Revenue10 834 000
Expenditure10 860 000
Operating Profit−27 000
Financial Income0
Financial Costs67 000
Financial Balance−67 000
Earnings Before Tax−94 000
Tax0
Net Income−94 000
Balance (NOK)2022
Total Fixed Assets395 000
Total Current Assets1 471 000
Total Assets1 866 000
Total Retained Equity−3 129 000
Total Equity−879 000
Total Long-Term Debt1 500 000
Total Current Debt1 245 000
Total Equity and Debt1 866 000
Cash flow (NOK)2022
Sales Income10 834 000
Other Income0
Revenue10 834 000
Cost of Goods Sold7 952 000
Salary Costs1 919 000
Depreciation124 000
Impairment0
Expenditure10 860 000
Operating Profit−27 000
Financial Income0
Financial Costs67 000
Financial Balance−67 000
Dividends0
Net Income−94 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures395 000
Total Tangible Assets395 000
Total Fiancial Fixed Assets0
Total Fixed Assets395 000
Stock916 000
Total Investments0
Cash, Bank372 000
Total Current Assets1 471 000
Total Assets1 866 000
Total Equity−879 000
Short-Term Group Debt0
Total Long-Term Debt1 500 000
Creditors864 000
Unpaid Taxes196 000
Dividends0
Other Current Debt185 000
Total Current Debt1 245 000
Total Equity and Debt1 866 000
Financial indicators2022
Return on Equity10,69 %
Debt-to-Equity Ratio−1,71
Operating Profit Margin−0,25 %
Current Ratio1,18
Quick Ratio4,47
Equity Ratio−0,47
Gross Profit Margin26,6 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English